High caffeine consumption may be associated with an increased risk of breast cancer in women with benign breast disease.
Although high caffeine consumption does not appear to increase the overall risk of breast cancer, it may be associated with an increased risk of breast cancer in women with benign breast disease, and for the development of estrogen receptor-negative and progesterone receptor-negative breast cancer and tumors larger than 2 cm, according to study findings published in the Oct. 13 issue of the Archives of Internal Medicine.
Ken Ishitani, MD, of Brigham and Womens Hospital and Harvard Medical School in Boston, and colleagues studied 38,432 women who were cancer-free in 1992–1995, including 1,188 who developed invasive breast cancer during a mean follow-up of 10 years.
Overall, the researchers found that women who drank at least four cups of coffee or at least two cups of tea per day did not have a higher risk of breast cancer than women who almost never drank these beverages. In women with benign breast disease, they found a borderline significant association between the highest quintile of caffeine consumption and increased risk (RR, 1.32). They also found a positive association between caffeine consumption and the risk of estrogen receptor-negative and progesterone receptor-negative breast cancer and tumors larger than 2 cm (RR, 1.68 and 1.79, respectively).
Ishitani K, Lin J, Manson JE, et al. Caffeine consumption and the risk of breast cancer in a large prospective cohort of women. Arch Intern Med. 2008;168:2022-2031.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More